pfizer glp-1 drug Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative race Pfizer GLP-1 weight loss drug

The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer

Always follow your providers guidance and reach out with any questions or concerns

While GLP-1...

#GLP1 #DiabetesCare #ObesityManagement #PharmaIndustry #ClinicalResearch #DrugDevelopment #HealthcareInnovation #Endocrinology #Biotech #RegulatoryAffairs

A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss in a phase 2b clinical trial.